{"entity":{"type":"insider","cik":"0001590862","url":"/insider/0001590862","json_url":"/insider/0001590862.json","name":"Meyers Pete A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2013-12-19","last":"2017-08-16","span_basis":"filed_date"},"name_variants":[{"name":"Meyers Pete A.","source":"filing","n_filings":4,"first_seen":"2014-12-08","last_seen":"2017-08-16"},{"name":"Meyers Peter A.","source":"filing","n_filings":2,"first_seen":"2013-12-19","last_seen":"2014-11-13"}],"transactions":[{"id":5175776,"accession":"0001209191-17-049317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-049317","line_url":"/filing/0001209191-17-049317#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001590862","owner_name":"Meyers Pete A.","owner_display_name":"Meyers Pete A.","owner_url":"/insider/0001590862","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350.0,"shares_display":"350","price_per_share":55.4468,"price_display":"55.45","price_state":"stated","total_value":19406.38,"total_display":"19,406.38","total_whole":"19,406","shares_owned_after":700.0,"shares_owned_after_display":"700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-16","scope":"insider"},{"id":4446455,"accession":"0001209191-17-039190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-039190","line_url":"/filing/0001209191-17-039190#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001590862","owner_name":"Meyers Pete A.","owner_display_name":"Meyers Pete A.","owner_url":"/insider/0001590862","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350.0,"shares_display":"350","price_per_share":71.4879,"price_display":"71.49","price_state":"stated","total_value":25020.765,"total_display":"25,020.76","total_whole":"25,021","shares_owned_after":350.0,"shares_owned_after_display":"350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-12","filed_date":"2017-06-12","scope":"insider"},{"id":8772262,"accession":"0001171843-15-001740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-15-001740","line_url":"/filing/0001171843-15-001740#line-1","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001590862","owner_name":"Meyers Pete A.","owner_display_name":"Meyers Pete A.","owner_url":"/insider/0001590862","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.35,"price_display":"4.35","price_state":"stated","total_value":21750.0,"total_display":"21,750.00","total_whole":"21,750","shares_owned_after":153891.0,"shares_owned_after_display":"153,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-27","filed_date":"2015-03-31","scope":"insider"},{"id":6454183,"accession":"0001171843-14-005800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-14-005800","line_url":"/filing/0001171843-14-005800#line-1","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001590862","owner_name":"Meyers Pete A.","owner_display_name":"Meyers Pete A.","owner_url":"/insider/0001590862","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1034.0,"shares_display":"1,034","price_per_share":4.94,"price_display":"4.94","price_state":"stated","total_value":5107.96,"total_display":"5,107.96","total_whole":"5,108","shares_owned_after":148891.0,"shares_owned_after_display":"148,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-04","filed_date":"2014-12-08","scope":"insider"},{"id":6554294,"accession":"0001192482-14-000236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-14-000236","line_url":"/filing/0001192482-14-000236#line-1","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001590862","owner_name":"Meyers Peter A.","owner_display_name":"Meyers Peter A.","owner_url":"/insider/0001590862","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.978,"price_display":"3.98","price_state":"stated","total_value":19890.0,"total_display":"19,890.00","total_whole":"19,890","shares_owned_after":147857.0,"shares_owned_after_display":"147,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-13","scope":"insider"},{"id":4693765,"accession":"0001192482-13-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-13-000245","line_url":"/filing/0001192482-13-000245#line-1","is_derivative":false,"issuer_cik":"0001361248","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001361248","owner_cik":"0001590862","owner_name":"Meyers Peter A.","owner_display_name":"Meyers Peter A.","owner_url":"/insider/0001590862","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":142857.0,"shares_display":"142,857","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":142857.0,"shares_owned_after_display":"142,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000827871","name":"EAGLE PHARMACEUTICALS, INC.","url":"/issuer/0000827871","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2017-06-12","last_seen":"2017-08-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001361248","name":"TETRALOGIC PHARMACEUTICALS CORP","url":"/issuer/0001361248","role":"Officer (CFO & Treasurer)","n_filings":4,"first_seen":"2013-12-19","last_seen":"2015-03-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001590862","retrieved_at":"2026-08-27T06:40:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}